Drug Trial Radar · NCT00711802
Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure Infections
Last checked: Nov 19, 2026Latest source record: Sep 5, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
396
Actual
Start
Jul 23, 2008
Primary completion
Oct 11, 2013
Study completion Oct 11, 2013
Sponsor
- Lead sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)Industry
- Sponsor type
- Industry
- First posted
- Jul 9, 2008
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 1 year, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multi-center, evaluator-blinded, randomized, comparative study designed to assess the safety, efficacy, and pharmacokinetics (PK) of daptomycin in pediatric subjects ages 1 to 17 years, inclusive, with complicated skin and skin structure infections (cSSSI) caused by Gram-positive pathogens.
Conditions
- Skin Diseases, Infectious
Interventions
DaptomycinDrug
Standard of Care (SOC)Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs)Time frame: Baseline through 14 days after last dose of study drug
Locations
30 sites in 3 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Children's Hospital Research Center Oakland
Oakland, California
Children's Hospital of Orange County
Orange, California
Rady Children's Hospital - San Diego
San Diego, California
University of South Florida College of Medicine
Tampa, Florida
Emory University
Atlanta, Georgia
University of Chicago
Chicago, Illinois
Children's Hospital of Michigan
Detroit, Michigan
University of Nebraska Medical Center
Omaha, Nebraska
Robert Wood Johnson Medical School
New Brunswick, New Jersey
SUNY Downstate Medical Center
Brooklyn, New York
Montifiore Medical Center
The Bronx, New York
Duke University Medical Center
Durham, North Carolina
Children's Hospital Medical Center of Akron
Akron, Ohio
University Hospitals Case Medical Center
Cleveland, Ohio
Toledo Children's Hospital
Toledo, Ohio
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma
LeBonheur Children's Medical Center
Memphis, Tennessee
Vanderbilt University Medical Center and Children's Hospital
Nashville, Tennessee
Cook Children's Medical Center
Fort Worth, Texas
Texas Children's Hospital
Houston, Texas
The University of Texas Health Science Center
Houston, Texas
Medisys Hospital
Bangalore, India
MS Ramaiah
Bangalore, India
MV Hospital and Research Center
Lucknow, India
BYL Nair Hospital
Mumbai, India
Lokmanya Tilak Municipal Medical College
Mumbai, India
KEM Hospital
Pune, India
Ruby Hall Clinic
Pune, India
Hospital Del Nino
Panama City, Panama
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.